Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol.

Dolci C, Spadavecchia C, Crivellaro C, De Ponti E, Todde S, Morzenti S, Turolla EA, Crespi A, Guerra L, Landoni C.

Phys Med. 2019 Jan;57:177-182. doi: 10.1016/j.ejmp.2018.12.038. Epub 2019 Jan 10.

PMID:
30738523
2.

Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry.

Turolla EA, Valtorta S, Bresciani E, Fehrentz JA, Giuliano L, Stucchi S, Belloli S, Rainone P, Sudati F, Rizzi L, Molteni L, Verdiè P, Martinez J, Torsello A, Moresco RM, Todde S.

Front Pharmacol. 2018 Nov 13;9:1274. doi: 10.3389/fphar.2018.01274. eCollection 2018.

3.

Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study.

Crivellaro C, De Ponti E, Elisei F, Morzenti S, Picchio M, Bettinardi V, Versari A, Fioroni F, Dziuk M, Tkaczewski K, Ahond-Vionnet R, Nodari G, Todde S, Landoni C, Guerra L.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):102-109. doi: 10.1007/s00259-017-3795-0. Epub 2017 Aug 19.

PMID:
28825125
4.

A novel versatile precursor suitable for 18 F-radiolabeling via "click chemistry".

Lugato B, Stucchi S, Ciceri S, Iannone MN, Turolla EA, Giuliano L, Chinello C, Todde S, Ferraboschi P.

J Labelled Comp Radiopharm. 2017 Aug;60(10):466-480. doi: 10.1002/jlcr.3529. Epub 2017 Aug 2.

PMID:
28600889
5.

European regulations for the introduction of novel radiopharmaceuticals in the clinical setting.

Decristoforo C, Penuelas I, Patt M, Todde S.

Q J Nucl Med Mol Imaging. 2017 Jun;61(2):135-144. doi: 10.23736/S1824-4785.17.02965-X. Epub 2017 Jan 26.

PMID:
28124548
6.

Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals.

Koziorowski J, Behe M, Decristoforo C, Ballinger J, Elsinga P, Ferrari V, Kolenc Peitl P, Todde S, Mindt TL.

EJNMMI Radiopharm Chem. 2017;1(1):1. doi: 10.1186/s41181-016-0004-6. Epub 2016 Mar 21. Erratum in: EJNMMI Radiopharm Chem. 2018 Nov 26;3:13.

7.

Guidance on validation and qualification of processes and operations involving radiopharmaceuticals.

Todde S, Peitl PK, Elsinga P, Koziorowski J, Ferrari V, Ocak EM, Hjelstuen O, Patt M, Mindt TL, Behe M.

EJNMMI Radiopharm Chem. 2017;2(1):8. doi: 10.1186/s41181-017-0025-9. Epub 2017 Jun 29.

8.

Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study.

Gaglio D, Valtorta S, Ripamonti M, Bonanomi M, Damiani C, Todde S, Negri AS, Sanvito F, Mastroianni F, Di Campli A, Turacchio G, Di Grigoli G, Belloli S, Luini A, Gilardi MC, Colangelo AM, Alberghina L, Moresco RM.

Oncotarget. 2016 Aug 9;7(32):52017-52031. doi: 10.18632/oncotarget.10470.

9.

VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells.

Curtarello M, Zulato E, Nardo G, Valtorta S, Guzzo G, Rossi E, Esposito G, Msaki A, Pastò A, Rasola A, Persano L, Ciccarese F, Bertorelle R, Todde S, Plebani M, Schroer H, Walenta S, Mueller-Klieser W, Amadori A, Moresco RM, Indraccolo S.

Cancer Res. 2015 Jan 1;75(1):120-33. doi: 10.1158/0008-5472.CAN-13-2037. Epub 2014 Nov 7.

10.

Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective.

Aerts J, Ballinger JR, Behe M, Decristoforo C, Elsinga PH, Faivre-Chauvet A, Mindt TL, Kolenc Peitl P, Todde SC, Koziorowski J; European Association of Nuclear Medicine.

J Labelled Comp Radiopharm. 2014 Aug;57(10):615-20. doi: 10.1002/jlcr.3227. Epub 2014 Sep 5.

11.

EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD).

Todde S, Windhorst AD, Behe M, Bormans G, Decristoforo C, Faivre-Chauvet A, Ferrari V, Gee AD, Gulyas B, Halldin C, Peitl PK, Koziorowski J, Mindt TL, Sollini M, Vercouillie J, Ballinger JR, Elsinga PH.

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2175-85. doi: 10.1007/s00259-014-2866-8.

PMID:
25081821
12.

18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.

Crivellaro C, Signorelli M, Guerra L, De Ponti E, Buda A, Dolci C, Pirovano C, Todde S, Fruscio R, Messa C.

Gynecol Oncol. 2012 Oct;127(1):131-5. doi: 10.1016/j.ygyno.2012.06.041. Epub 2012 Jul 6.

PMID:
22772064
13.

A methodology to investigate the intrinsic effect of the pulsed electric current during the spark plasma sintering of electrically conductive powders.

Locci AM, Cincotti A, Todde S, Orrù R, Cao G.

Sci Technol Adv Mater. 2010 Oct 19;11(4):045005. eCollection 2010 Aug.

14.

Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.

Elsinga P, Todde S, Penuelas I, Meyer G, Farstad B, Faivre-Chauvet A, Mikolajczak R, Westera G, Gmeiner-Stopar T, Decristoforo C; Radiopharmacy Committee of the EANM.

Eur J Nucl Med Mol Imaging. 2010 May;37(5):1049-62. doi: 10.1007/s00259-010-1407-3.

15.

Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons.

Calandrino R, del Vecchio A, Parisi R, Todde S, De Felice P, Savi A, Pepe A, Mrskova A.

Radiat Prot Dosimetry. 2010 Jun;139(4):477-82. doi: 10.1093/rpd/ncp283. Epub 2009 Dec 22.

PMID:
20028699
16.

Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility.

Calandrino R, del Vecchio A, Savi A, Todde S, Belloli S.

Health Phys. 2009 Oct;97(4):315-21. doi: 10.1097/HP.0b013e3181ad8192.

PMID:
19741360
17.

Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies.

Matarrese M, Bedeschi P, Scardaoni R, Sudati F, Savi A, Pepe A, Masiello V, Todde S, Gianolli L, Messa C, Fazio F.

Appl Radiat Isot. 2010 Jan;68(1):5-13. doi: 10.1016/j.apradiso.2009.08.010. Epub 2009 Aug 25.

PMID:
19736021
18.

Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation.

Moresco RM, Lavazza T, Belloli S, Lecchi M, Pezzola A, Todde S, Matarrese M, Carpinelli A, Turolla E, Zimarino V, Popoli P, Malgaroli A, Fazio F.

Eur J Nucl Med Mol Imaging. 2008 Apr;35(4):704-15. Epub 2007 Dec 15.

PMID:
18080815
19.

Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application.

Ottobrini L, Ciana P, Moresco R, Lecchi M, Belloli S, Martelli C, Todde S, Fazio F, Gambhir SS, Maggi A, Lucignani G.

Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):365-78. Epub 2007 Oct 10.

PMID:
17926035
20.

Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography.

Filannino MA, Matarrese M, Turolla EA, Masiello V, Moresco RM, Todde S, Verza E, Magni F, Cattaneo A, Bachi A, Kienle MG, Fazio F.

Appl Radiat Isot. 2007 Nov;65(11):1232-9. Epub 2007 Jun 26.

PMID:
17646106

Supplemental Content

Support Center